I help healthcare and diagnostics startups get products into clinical guidelines and doctor workflows
25 years in product, the last 15 in healthcare and diagnostics. At GRAIL I launched Galleri, the first multi-cancer early detection blood test, and helped scale the company from pre-revenue to a $1B+ commercial diagnostics business: 400,000+ tests ordered, 15,000+ providers, 40+ health system partners. With Artera's founding team I shipped the first AI-based test included in NCCN guidelines for prostate cancer. At Helix I ran product through the pivot to population genomics, including a 100,000-participant sequencing partnership with Mayo Clinic.
Through Accelera Bio I've been a fractional product leader for 15+ healthtech startups across YC and Khosla portfolios.
What I do: move diagnostics and healthcare products from R&D to clinical adoption. Evidence strategy, regulatory path, the channel to launch ahead of reimbursement, and the work to get into guidelines and physician workflows. If you're commercializing a test or a clinical product, that's the problem I solve.
A short call to see if your stage and problem are a fit for working together.
Direct guidance on the path into clinical guidelines and physician workflows. Bring your product, your claims, and your current evidence.
Working session for your team. We pressure-test your launch and leave with a prioritized sequence and the two or three decisions that gate it: channel, evidence, and the path into guidelines. Scoped for companies preparing to commercialize. Share existing GTM materials in advance.